Get startedLog in
    Picture of Soleno Therapeutics logo

    SLNO — Soleno Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapFalling Star
    All News

    Neurocrine nears $2.5 billion deal for Soleno Therapeutics, FT reports

    Picture of Soleno Therapeutics logoSoleno Therapeutics
    06/04/2026 03:55
    Fixes syntax in paragraph 1

April 5 (Reuters) - Drugmaker Neurocrine Biosciences NBIX.O is nearing a more than $2.5 billion acquisition of Soleno Therapeutics SLNO.O, the Financial Times reported on Sunday.

Reuters could not immediately confirm the report.

 (Reporting by Gnaneshwar Rajan in Bengaluru; Editing by Sumana Nandy)

 ((Gnaneshwar.Rajan@thomsonreuters.com;))

    Recent news on Soleno Therapeutics

    See all news